Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar-Apr;3(2):121-34.
doi: 10.4161/gmic.19399. Epub 2012 Mar 1.

Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response

Affiliations
Review

Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response

Gayatri Vedantam et al. Gut Microbes. 2012 Mar-Apr.

Abstract

Clostridium difficile infection is the leading cause of antibiotic- and healthcare-associated diarrhea, and its containment and treatment imposes a significant financial burden, estimated to be over $3 billion in the USA alone. Since the year 2000, CDI epidemics/outbreaks have occurred in North America, Europe and Asia. These outbreaks have been variously associated with, or attributed to, the emergence of Clostridium difficile strains with increased virulence, an increase in resistance to commonly used antimicrobials such as the fluoroquinolones, or host susceptibilities, including the use of gastric acid suppressants, to name a few. Efforts to elucidate C. difficile pathogenic mechanisms have been hampered by a lack of molecular tools, manipulatable animal models, and genetic intractability of clinical C. difficile isolates. However, in the past 5 y, painstaking efforts have resulted in the unraveling of multiple C. difficile virulence-associated pathways and mechanisms. We have recently reviewed the disease, its associated risk factors, transmission and interventions (Viswanathan, Gut Microbes 2010). This article summarizes genetics, non-toxin virulence factors, and host-cell biology associated with C. difficile pathogenesis as of 2011, and highlights those findings/factors that may be of interest as future intervention targets.

PubMed Disclaimer

Figures

None
Figure 1. Schematic of human C. difficile infection. Spores, vegetative cells, bacterial factors and host factors that impact/modulate disease are depicted.
None
Figure 2. Spore surface of C. difficile clinical isolates. High-resolution, scanning electron micrograph overlayed with transmission-electron micrograph data of spore morphology of C. difficile strain VPI10463 immobilized on a solid surface. The orderly arrangement of spore protein complexes is clearly visible, as is an exosporial structure (diffusely-shaped and surrounding the spore. Micrograph collection, Vedantam laboratory.
None
Figure 3.C. difficile spores and vegetative cells adhere to host intestinal epithelium. False-color, high resolution, scanning electron micrograph of C. difficile spore (blue) and vegetative cell (red) adhering to human intestinal epithelial cells (green) grown in culture. Microvilli are clearly visible (feather-like green protrusions). Micrograph collection, Vedantam laboratory.
None
Figure 4.C. difficile clinical isolates produce flagella. False-color, high-resolution, scanning electron micrograph of a C. difficile ribotype 001 strain. Flagella (red) are clearly visible on vegetative cells (purple) after growth to exponential phase (OD600 = 0.6) in Brain-Heart infusion medium supplemented with yeast and cysteine. Biophysical measurements indicate that flagella have a diameter of 17–22 nm, consistent with those described on other enteric bacteria. Micrograph collection, Vedantam laboratory.

References

    1. Barbut F, Jones G, Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update. Curr Opin Infect Dis. 2011;24:370–6. doi: 10.1097/QCO.0b013e32834748e5. - DOI - PubMed
    1. Sorg JA, Sonenshein AL. Chenodeoxycholate is an inhibitor of Clostridium difficile spore germination. J Bacteriol. 2009;191:1115–7. doi: 10.1128/JB.01260-08. - DOI - PMC - PubMed
    1. Viswanathan VK, Mallozzi MJ, Vedantam G. Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes. 2010;1:234–42. doi: 10.4161/gmic.1.4.12706. - DOI - PMC - PubMed
    1. Killgore G, Thompson A, Johnson S, Brazier J, Kuijper E, Pepin J, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008;46:431–7. doi: 10.1128/JCM.01484-07. - DOI - PMC - PubMed
    1. Tenover FC, Akerlund T, Gerding DN, Goering RV, Boström T, Jonsson AM, et al. Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol. 2011;49:1831–7. doi: 10.1128/JCM.02446-10. - DOI - PMC - PubMed

Publication types

MeSH terms